$0
0
0.00%
$15.5
Joel Greenblatt started to build up the position in Iovance Biotherapeutics in Q1 2022. Since then they sold 10.4 Thousand shares. The investor sold all their shares in Q2 2022 and doesn't own any shares in Iovance Biotherapeutics anymore.
Easily embed the chart on your blog or website – it will always update automatically!